Breaking News Instant updates and real-time market news.

IQ

iQIYI

$18.32

0.6 (3.39%)

, CTRP

Ctrip

$30.25

-0.65 (-2.10%)

05:37
01/24/19
01/24
05:37
01/24/19
05:37

iQIYI, Ctrip expand strategic cooperation in shared membership

iQIYI (IQ) announced a deepening of its partnership in joint premium membership benefits with Ctrip (CTRP). Under the agreement, members who purchase iQIYI Diamond VIP or QIYIGUO year card benefits on the iQIYI platform will be able to claim the benefits of Ctrip Prime members, including the use of Ctrip's VIP airport lounges, priority access for purchasing train tickets, discounts on hotel bookings, vehicle reservation, entry to sightseeing attractions and more. Similarly, customers who become Ctrip Prime members can activate an iQIYI 8-month VIP membership and enjoy access to VIP exclusive content, members-only audio-visual experiences, attendance at exclusive offline events and more.

IQ

iQIYI

$18.32

0.6 (3.39%)

CTRP

Ctrip

$30.25

-0.65 (-2.10%)

IQ iQIYI
$18.32

0.6 (3.39%)

10/31/18
FBCO
10/31/18
UPGRADE
FBCO
Outperform
iQIYI upgraded to Outperform from Neutral at Credit Suisse
12/12/18
HSBC
12/12/18
INITIATION
Target $22
HSBC
Hold
iQIYI initiated with a Hold at HSBC
HSBC initiated iQIYI with a Hold and $22 price target.
12/12/18
12/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Foamix (FOMX) initiated with a Buy at BofA/Merrill. 2. Jazz Pharmaceuticals (JAZZ) initiated with an Outperform at Oppenheimer while GW Pharmaceuticals (GWPH) was initiated with a Perform. 3. Six Flags (SIX) initiated with a Buy at Berenberg. 4. iQIYI (IQ) initiated with a Hold at HSBC. 5. Intercept (ICPT), Viking Therapeutics (VKTX), and Galmed (GLMD) were initiated with a Buy at B. Riley FBR, while Madrigal Pharmaceuticals (MDGL) initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/14/19
OTRG
01/14/19
DOWNGRADE
OTRG
Mixed
iQIYI downgraded to Mixed from Positive at OTR Global
CTRP Ctrip
$30.25

-0.65 (-2.10%)

12/12/18
MZHO
12/12/18
DOWNGRADE
MZHO
Neutral
Ctrip downgraded to Neutral from Buy at Mizuho
12/12/18
MZHO
12/12/18
DOWNGRADE
MZHO
Neutral
Ctrip assumed with a Neutral at Mizuho
Mizuho analyst James Lee assumed coverage of Ctrip with a Neutral rating and $31 price target, down from the firm's prior Buy rating. He believes "the bar has been reset" for macro uncertainties and thinks competition concerns about Meituan Dianping are overstated, he tells investors.
01/03/19
BNCH
01/03/19
NO CHANGE
BNCH
Activision, Canopy Growth among Best Ideas for first half of 2019 at Benchmark
Benchmark analysts selected their Best Ideas for the first half of 2019, naming 16 stocks, including: Activision Blizzard (ATVI), BioTelemetry (BEAT), Biofrontera (BFRA), Ctrip (CTRP), Huazhu Group (HTHT), II-VI (IIVI), Intevac (IVAC), LHC Group (LHCG), Meredith (MDP), Marvell (MRVL), NeoGenomics (NEO), Pegasystems (PEGA), Silicon Labs (SLAB), Varonis (VRNS), Canopy Growth (CGC) and Waitr Holdings (WTRH).
01/14/19
BERN
01/14/19
INITIATION
Target $32
BERN
Market Perform
Ctrip assumed with a Market Perform at Bernstein
Bernstein analyst David Dai assumed coverage on Ctrip with a Market Perform and $32 price target.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.